The global demand for Dry Eye Syndrome Treatment Market is presumed to reach the market size of nearly USD 15.98 MN by 2028 from USD 7.98 MN in 2021 with a CAGR of 10.43% under the study period 2022 - 2028.
In dry eye syndrome the surface of the affected person's eyes lacks lubrication or moisture. The most common symptoms include irritation, redness, discharge, blurred vision, and easily fatigued eyes. Dry eye symptoms can be treated by identifying the cause of the disease, including treatments such as lubricant treatments, anti-inflammatory treatments, autologous serum eye drops, and surgery. Dry eye syndrome treatment can include lifestyle changes and eyedrops.
Market Dynamics
The rising cases of dry eye syndrome and increasing demand for its treatment for relieving its symptoms is a major factor driving the growth of the dry eye syndrome treatment market. Moreover, the sharp rise in various eye diseases due to the increasing usage of electronic gadgets such as cell phones, tablets and laptops has generated immense demand for dry eye syndrome treatments during the forecast period. Furthermore, the increase in investment in research and development by pharmaceutical companies in new therapeutics can greatly impact the global market. The growing geriatric population and increasing public awareness about dry eye problems will accelerate the market's growth rate. However, the high cost associated with treatment will obstruct the dry eye syndrome treatments market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of dry eye syndrome treatment. The growth and trends of dry eye syndrome treatment industry provide a holistic approach to this study.
Market Segmentation
This section of the dry eye syndrome treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Product
- Cyclosporine
- Topical Corticosteroids
- Artificial Tears
- Punctal Plugs (Removable, Dissolvable)
- Oral Omega Supplements
- Others
By Prescription
By Distribution Channel
- Hospital Pharmacies
- Eye Health Clinics
- Retail Pharmacies
- Online Pharmacies
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Dry Eye Syndrome Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Dry Eye Syndrome Treatment Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the dry eye syndrome treatment market include Allergen plc. (Abbvie), Novartis AG, Otsuka Pharmaceuticals Co. Ltd., Bausch Health Companies Inc. Akron Inc., Johnson & Johnson Inc., Thea Pharmaceuticals Limited, OASIS Medical, Altaire Pharmaceuticals Inc., Boiron USA, Similasan Corporation, Scope Ophthalmics Ltd., Reckitt Benckiser Group PLC, Medicom Healthcare Ltd, FDC Limited., Lupin Limited, Jamjoom Pharmaceuticals Co., and Sentiss Pharma Private limited. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
